These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26300696)

  • 1. Cost-effectiveness analysis of routine immunization and supplementary immunization activity for measles in a health district of Benin.
    Kaucley L; Levy P
    Cost Eff Resour Alloc; 2015; 13():14. PubMed ID: 26300696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study.
    Gargano LM; Tate JE; Parashar UD; Omer SB; Cookson ST
    Confl Health; 2015; 9():5. PubMed ID: 25691915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi.
    Kainga HW; Ssendagire S; Ssanyu JN; Nabukeera S; Namuhani N; Mangen FW
    PLoS One; 2021; 16(1):e0243137. PubMed ID: 33428640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
    Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
    Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
    Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
    Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal.
    Wallace AS; Bohara R; Stewart S; Subedi G; Anand A; Burnett E; Giri J; Shrestha J; Gurau S; Dixit S; Rajbhandari R; Schluter WW
    J Infect Dis; 2017 Jul; 216(suppl_1):S280-S286. PubMed ID: 28838201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of supplementary immunization for measles in India.
    Dabral M
    Indian Pediatr; 2009 Nov; 46(11):957-62. PubMed ID: 19578225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supplementary immunization activities (SIAs) in South Africa: comprehensive economic evaluation of an integrated child health delivery platform.
    Verguet S; Jassat W; Bertram MY; Tollman SM; Murray CJ; Jamison DT; Hofman KJ
    Glob Health Action; 2013 Mar; 6():1-9. PubMed ID: 23458088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
    Yang Y; Kostandova N; Mwansa FD; Nakazwe C; Namukoko H; Sakala C; Bobo P; Masumbu PK; Nachinga B; Ngula D; Carcelen AC; Prosperi C; Winter AK; Moss WJ; Mutembo S
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunization coverage of children aged 0 to 5 years in Libreville (Gabon)].
    Ategbo S; Ngoungou EB; Koko J; Vierin Y; Zang Ndong CE; Moussavou Mouyama A
    Sante; 2010; 20(4):215-9. PubMed ID: 21266317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of supplemental immunization activities to deliver measles immunization to children in Anambra state, south-east Nigeria.
    Sibeudu FT; Onwujekwe OE; Okoronkwo IL
    Vaccine; 2020 Aug; 38(37):5947-5954. PubMed ID: 32651114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.
    Mak J; Patenaude BN; Mutembo S; Pilewskie ME; Winter AK; Moss WJ; Carcelen AC
    Am J Trop Med Hyg; 2024 Jul; 111(1):121-128. PubMed ID: 38772386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the introduction of new vaccines and vaccine wastage rate on the cost-effectiveness of routine EPI: lessons from a descriptive study in a Cameroonian health district.
    Ebong CE; Levy P
    Cost Eff Resour Alloc; 2011 May; 9(1):9. PubMed ID: 21619674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia.
    Gargano LM; Hajjeh R; Cookson ST
    Prehosp Disaster Med; 2015 Aug; 30(4):402-11. PubMed ID: 26061190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002.
    Vijayaraghavan M; Martin RM; Sangrujee N; Kimani GN; Oyombe S; Kalu A; Runyago A; Wanjau G; Cairns L; Muchiri SN
    Health Policy; 2007 Sep; 83(1):27-36. PubMed ID: 17174435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updating the evidence base on the operational costs of supplementary immunization activities for current and future accelerated disease control, elimination and eradication efforts.
    Gandhi G; Lydon P
    BMC Public Health; 2014 Jan; 14():67. PubMed ID: 24450832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost-effectiveness analysis of traditional and geographic information system-supported microplanning approaches for routine immunization program management in northern Nigeria.
    Ali D; Levin A; Abdulkarim M; Tijjani U; Ahmed B; Namalam F; Oyewole F; Dougherty L
    Vaccine; 2020 Feb; 38(6):1408-1415. PubMed ID: 31924428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of routine immunization costing in Benin and Ghana in 2011.
    Ahanhanzo CD; Huang XX; Le Gargasson JB; Sossou J; Nyonator F; Colombini A; Gessner BD
    Vaccine; 2015 May; 33 Suppl 1():A66-71. PubMed ID: 25919178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.